Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares climbed 103.8% to $4.8901 after the company announced it has received ‘intention to grant’ patents from European and Israeli patent offices.

More 34 Stocks Moving In Tuesday’s Mid-Day Session Videos